Effects of Soy Protein on Body Composition and General Health in Healthy Children

A Randomized, Controlled, Parallel Study to Assess the Effects of Soy Protein on Body Composition and General Health Parameters in Healthy Children

The aim of this clinical trial is to assess the effects of daily consumption of soy protein foods on body composition, general health status and dietary intake outcomes in generally healthy children.

Study Overview

• Status: Completed
• Conditions: Generally Healthy Kids Consumption Soy Protein Foods as Part of Daily Diet
• Intervention / Treatment: Behavioral: Dietary Guidance; Other: Soy protein containing foods

• Study Type: Interventional
• Enrollment (Actual): 47
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Illinois
    • Addison, Illinois, United States, 60101
      • Biofortis Clinical Research

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 8 years to 11 years (Child)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Subject is male or female, 8-11 years of age, inclusive.
2. Subject is judged to be in good health on the basis of medical history.
3. Subject is a regular consumer (5 out of 7 d) of breakfast and snacks.
4. Subject has a BMI-for-age within the 75th and 95th percentile (Appendix 3).
5. Subject is willing to follow dietary changes consistent with the Dietary Guidelines for Americans 2010 throughout the study period (Appendix 5).
6. Subject/guardian understands the study procedures and signs forms providing assent/informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators.

Exclusion Criteria:

1. Subject has a diagnosis of attention deficit disorder, with or without hyperactivity.
2. Subject requires special educational services related to cognitive or attentional disorders, neurologic diseases, and physical disabilities.
3. Subject is a girl who has begun menses.
4. Subject is at Tanner Stage IV or higher, as described by parent/guardian per self-assessment questionnaire (Appendix 2).
5. Subject has a history or presence of a clinically relevant cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder.
6. Subject has a known allergy or sensitivity to the study foods.
7. Use of sleep aids within 2 weeks of visit 1 (week -1) and throughout the study.
8. Subject has extreme dietary habits, in the judgment of the Investigator.
9. Subject has used any weight loss supplements, programs, or meal replacement products (within 2 weeks of visit 1, week -1) intended to alter body weight (Appendix 1).
10. Subject has a history of an eating disorder (e.g., anorexia nervosa, bulimia nervosa or binge eating) diagnosed by a health professional.
11. Involvement in any clinical trial within 30 d prior to the screening visit.
12. Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Usual Protein Group; Subjects will be instructed on the 2010 Dietary Guidelines for Americans including publically available information from the United States Department of Agricultural (USDA) MyPlate program (www.choosemyplate.gov). Subjects in this intervention group will not receive study provided foods.	Behavioral: Dietary Guidance; Subjects will be instructed on the 2010 Dietary Guidelines for Americans including publically available information from the United States Department of Agricultural (USDA) MyPlate program (www.choosemyplate.gov). Subjects in this intervention group will not receive study provided foods.
Experimental: Soy Protein Group; Subjects will be instructed on the 2010 Dietary Guidelines for Americans including publically available information from the USDA MyPlate program (www.choosemyplate.gov) with the incorporation of two servings of study food providing soy protein per day.	Other: Soy protein containing foods; Daily consumption of 2 food products, each providing 15g of soy protein per day.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
change in body composition	DXA	week 0, week 12

Collaborators and Investigators

• Sponsor: DuPont Nutrition and Health
• Collaborators: BioFortis

Study record dates

Study Major Dates

• Study Start: February 1, 2015
• Primary Completion (Actual): August 1, 2015
• Study Completion (Actual): August 1, 2015

Study Registration Dates

• First Submitted: March 17, 2015
• First Submitted That Met QC Criteria: April 7, 2015
• First Posted (Estimate): April 10, 2015

Study Record Updates

• Last Update Posted (Actual): October 4, 2019
• Last Update Submitted That Met QC Criteria: October 3, 2019
• Last Verified: October 1, 2019

More Information

Terms related to this study

• Other Study ID Numbers: BIO-1501